28359307|t|Clinical impact of postoperative loss in psoas major muscle and nutrition index after radical cystectomy for patients with urothelial carcinoma of the bladder
28359307|a|Although the significance of preoperative nutritional status has been investigated, there is no report regarding the relationship of their postoperative changes on outcomes in patients who underwent radical cystectomy for bladder cancer. Here, we report the clinical impact of the change, from baseline, in nutritional status and volume of abdominal skeletal muscle mass and adipose tissue after radical cystetomy. A retrospective analysis of 89 patients with bladder cancer, who underwent curative radical cystectomy, was conducted to assess the time course of change, from baseline, in body composition and nutritional status at 1, 3, 6, 12, and 24 months, after surgery. Skeletal muscle mass and abdominal adipose tissue mass were quantified by unenhanced computed tomography images. Two different nutritional indices, the Prognostic Nutritional Index and the Controlling Nutritional Status score were calculated from laboratory blood tests. We evaluated the prognostic value of the rate of change in the body composition and nutritional status after radical cystectomy. The cross-sectional area at the level of the third lumbar vertebra of the psoas major muscle and nutritional indices showed a transient deterioration at 1 and 3 months after radical cystectomy, with a return to baseline values from 6 to 24 months. A ≤ -10% loss in the area of the psoas muscle was associated with a shorter overall survival, compared to those with a > -10 change [hazard ratio (HR) 2.2, P = 0.02]. Multivariate analyzes identified sarcopenia status at baseline (HR 2.2, P = 0.03) and a ≤ -10% loss in the psoas muscle (HR 2.4, P = 0.02) were identified as independent prognostic factors for overall survival. A subanalysis of patients without sarcopenia identified a worse survival outcome for patients with a ≤ -10% loss in the psoas muscle (HR 2.6, P = 0.03) and ≤ - 5 change in the Prognostic Nutritional Index (HR 3.6, P = 0.01). Further research is required to establish appropriate rehabilitation protocols and nutritional interventions after radical cystectomy for maintaining skeletal muscle mass and nutrition status which could counteract physical deterioration and improve outcomes.
28359307	0	15	Clinical impact	T080	C4049986
28359307	19	37	postoperative loss	T046	C0030660
28359307	41	59	psoas major muscle	T023	C0224419
28359307	64	79	nutrition index	T081	C0028710
28359307	86	104	radical cystectomy	T061	C0194401
28359307	109	117	patients	T101	C0030705
28359307	123	143	urothelial carcinoma	T191	C2145472
28359307	151	158	bladder	T023	C0005682
28359307	188	200	preoperative	T079	C0445204
28359307	201	219	nutritional status	T033	C0392209
28359307	229	241	investigated	T169	C1292732
28359307	255	261	report	T170	C0684224
28359307	276	288	relationship	T080	C0439849
28359307	298	319	postoperative changes	T046	C0030660
28359307	323	331	outcomes	T169	C1274040
28359307	335	343	patients	T101	C0030705
28359307	358	376	radical cystectomy	T061	C0194401
28359307	381	395	bladder cancer	T191	C0699885
28359307	406	412	report	T058	C0700287
28359307	417	432	clinical impact	T080	C4049986
28359307	440	446	change	T169	C0392747
28359307	453	461	baseline	T081	C1442488
28359307	466	484	nutritional status	T033	C0392209
28359307	489	495	volume	T081	C0449468
28359307	499	508	abdominal	T029	C0000726
28359307	509	524	skeletal muscle	T024	C0242692
28359307	525	529	mass	T081	C0392762
28359307	534	548	adipose tissue	T024	C0001527
28359307	555	572	radical cystetomy	T061	C0194401
28359307	576	598	retrospective analysis	T062	C0035363
28359307	605	613	patients	T101	C0030705
28359307	619	633	bladder cancer	T191	C0699885
28359307	649	676	curative radical cystectomy	T061	C0194401
28359307	695	701	assess	T058	C0184514
28359307	706	717	time course	T079	C0449247
28359307	721	727	change	T169	C0392747
28359307	734	742	baseline	T081	C1442488
28359307	747	763	body composition	T032	C0005885
28359307	768	786	nutritional status	T033	C0392209
28359307	810	816	months	T079	C0439231
28359307	818	831	after surgery	T033	C0241311
28359307	833	848	Skeletal muscle	T024	C0242692
28359307	849	853	mass	T081	C0392762
28359307	858	867	abdominal	T029	C0000726
28359307	868	882	adipose tissue	T024	C0001527
28359307	883	887	mass	T081	C0392762
28359307	893	903	quantified	T081	C1709793
28359307	918	937	computed tomography	T060	C0040405
28359307	938	944	images	T170	C1704254
28359307	960	979	nutritional indices	T081	C0028710
28359307	985	1013	Prognostic Nutritional Index	T081	C0033326
28359307	1022	1052	Controlling Nutritional Status	T033	C0392209
28359307	1053	1058	score	T081	C0449820
28359307	1064	1074	calculated	T052	C1441506
28359307	1080	1102	laboratory blood tests	T059	C0018941
28359307	1107	1116	evaluated	T058	C0220825
28359307	1121	1137	prognostic value	T081	C0449821
28359307	1145	1149	rate	T081	C1521828
28359307	1153	1159	change	T169	C0392747
28359307	1167	1183	body composition	T032	C0005885
28359307	1188	1206	nutritional status	T033	C0392209
28359307	1213	1231	radical cystectomy	T061	C0194401
28359307	1237	1257	cross-sectional area	T082	C1254362
28359307	1265	1270	level	T080	C0441889
28359307	1278	1299	third lumbar vertebra	T023	C0223522
28359307	1307	1325	psoas major muscle	T023	C0224419
28359307	1330	1349	nutritional indices	T081	C0028710
28359307	1359	1368	transient	T079	C0205374
28359307	1369	1382	deterioration	T067	C0868945
28359307	1394	1400	months	T079	C0439231
28359307	1407	1425	radical cystectomy	T061	C0194401
28359307	1444	1452	baseline	T081	C1442488
28359307	1453	1459	values	T081	C1522609
28359307	1473	1479	months	T079	C0439231
28359307	1490	1494	loss	T081	C1517945
28359307	1502	1506	area	T082	C0205146
28359307	1514	1526	psoas muscle	T023	C0085221
28359307	1531	1546	associated with	T080	C0332281
28359307	1557	1573	overall survival	T081	C4086681
28359307	1606	1612	change	T169	C0392747
28359307	1614	1626	hazard ratio	T081	C2985465
28359307	1628	1630	HR	T081	C2985465
28359307	1648	1669	Multivariate analyzes	T081	C0026777
28359307	1670	1680	identified	T080	C0205396
28359307	1681	1691	sarcopenia	T047	C0872084
28359307	1692	1698	status	T080	C0449438
28359307	1702	1710	baseline	T081	C1442488
28359307	1712	1714	HR	T081	C2985465
28359307	1743	1747	loss	T081	C1517945
28359307	1755	1767	psoas muscle	T023	C0085221
28359307	1769	1771	HR	T081	C2985465
28359307	1792	1802	identified	T080	C0205396
28359307	1806	1817	independent	T078	C0085862
28359307	1818	1836	prognostic factors	T201	C1514474
28359307	1841	1857	overall survival	T081	C4086681
28359307	1861	1872	subanalysis	T062	C0936012
28359307	1876	1884	patients	T101	C0030705
28359307	1893	1903	sarcopenia	T047	C0872084
28359307	1904	1914	identified	T080	C0205396
28359307	1917	1922	worse	T033	C1457868
28359307	1923	1931	survival	T052	C0038952
28359307	1932	1939	outcome	T169	C1274040
28359307	1944	1952	patients	T101	C0030705
28359307	1967	1971	loss	T081	C1517945
28359307	1979	1991	psoas muscle	T023	C0085221
28359307	1993	1995	HR	T081	C2985465
28359307	2021	2027	change	T169	C0392747
28359307	2035	2063	Prognostic Nutritional Index	T081	C0033326
28359307	2065	2067	HR	T081	C2985465
28359307	2092	2100	research	T062	C0035168
28359307	2138	2152	rehabilitation	T169	C0034992
28359307	2153	2162	protocols	T170	C0442711
28359307	2167	2192	nutritional interventions	T061	C0086153
28359307	2199	2217	radical cystectomy	T061	C0194401
28359307	2234	2249	skeletal muscle	T024	C0242692
28359307	2250	2254	mass	T081	C0392762
28359307	2259	2275	nutrition status	T033	C0392209
28359307	2299	2321	physical deterioration	T184	C1386058
28359307	2326	2333	improve	T033	C0184511
28359307	2334	2342	outcomes	T169	C1274040